Literature DB >> 10674362

Proton magnetic resonance spectroscopy of lenticular nuclei in obsessive-compulsive disorder.

K Ohara1, H Isoda, Y Suzuki, Y Takehara, M Ochiai, H Takeda, Y Igarashi, K Ohara1.   

Abstract

Magnetic resonance spectroscopy (MRS) is a safe and non-invasive technique for the in vivo study of brain chemistry and metabolism. As such, it is highly applicable to the study of living brain tissue in psychiatric diseases. Several neuropathological and neuroimaging studies have suggested that abnormalities of the basal ganglia nuclei might be implicated in patients with obsessive-compulsive disorder (OCD). In the present study, we performed proton [1H]MRS of the lenticular nuclei in 12 patients with OCD and 12 healthy normal comparison subjects. The peaks of N-acetyl-aspartate (NAA), creatine (Cr), and choline-containing compounds (Cho) were measured. No differences between OCD patients and normal subjects were found in the NAA/Cr, Cho/Cr and NAA/Cho ratios. Our results suggest the normal viability of neuronal cells, as indicated by the quantification of NAA, Cr and Cho in the lenticular nuclei of patients with OCD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10674362     DOI: 10.1016/s0925-4927(99)00040-2

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.

Authors:  Raşit Tükel; Kubilay Aydın; Erhan Ertekin; Seda Şahin Özyıldırım; Mehmet Barburoğlu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

2.  Magnetic Resonance Spectroscopy (MRS) and Positron Emission Tomography (PET) Imaging in Obsessive-Compulsive Disorder.

Authors:  Marjan Biria; Lucia-Manuela Cantonas; Paula Banca
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 3.  Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; John H Krystal; Vladimir Coric
Journal:  NeuroRx       Date:  2006-01

Review 4.  A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder.

Authors:  Brian P Brennan; Scott L Rauch; J Eric Jensen; Harrison G Pope
Journal:  Biol Psychiatry       Date:  2012-07-24       Impact factor: 13.382

5.  Reduction of N-acetylaspartate in the medial prefrontal cortex correlated with symptom severity in obsessive-compulsive disorder: meta-analyses of (1)H-MRS studies.

Authors:  Yuta Aoki; Ai Aoki; Hiroshi Suwa
Journal:  Transl Psychiatry       Date:  2012-08-14       Impact factor: 6.222

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.